| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.33M | - | |
| CFO | 58.4K | $16.49M | - | |
| VP | 29.8K | $8.40M | - | |
| VP | 23.7K | $6.69M | - | |
| Dir | 23.2K | $6.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2020 | Paul Steven M | Director | Sale+OE | 15,000 | $140.00 | $2,100,000.00 | -93.8% | |
| Nov 25, 2020 | Sharp Phillip A45 | Director | Sale+OE | 30,000 | $124.89 | $3,746,749.17 | -3.0% | |
| Nov 19, 2020 | Maraganore John | Chief Executive Officer | Sale+OE | 34,765 | $124.23 | $4,319,025.15 | -4.1% | |
| Sep 29, 2020 | Vaishnaw Akshay56 | President, R&D | Sale+OE | 971 | $140.00 | $135,940.00 | -6.4% | |
| Sep 9, 2020 | Greene Barry E | President | Sale+OE | 44,530 | $123.23 | $5,487,594.49 | -15.4% | |
| Aug 20, 2020 | Maraganore John | Chief Executive Officer | Sale+OE | 34,765 | $136.13 | $4,732,542.23 | -5.2% | |
| Jul 13, 2020 | Keating Laurie55 | EVP, Chief Legal Officer | Sale+OE | 47,250 | $160.67 | $7,591,790.43 | -21.2% | |
| Jul 10, 2020 | Greenstreet Yvonne49 | Chief Operating Officer | Sale+OE | 46,639 | $161.00 | $7,508,879.00 | -90.6% | |
| Jul 9, 2020 | Greenstreet Yvonne49 | Chief Operating Officer | Sale+OE | 11,236 | $161.00 | $1,808,996.00 | -70.0% | |
| Jul 7, 2020 | Greene Barry E | President | Sale+OE | 22,265 | $159.99 | $3,562,177.35 | -26.3% |